In summary, unvaccinated transplant patients with prior SARS-CoV-2 non-Omicron infection, or patients vaccinated with three doses of mRNA vaccine, may be at risk for symptomatic or severe omicron infection, owing to comparatively lower heterotypic antibody and CD4+ T-cell responses to Omicron BA.1. The gene discussed is CD4; the disease is infection.